5560 Federal Register / Vol. 69, No. 24 / Thursday, February 5, 2004 / Notices 

Boulevard, Bethesda, MD 20892–8401. (301) 

435–1439. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, SBIR—

‘‘Develop Screening and/or Assessment Tools 

for Multi-Problem Youth’’ (Topic 061). 

Date: February 18, 2004. 

Time: 9 a.m. to 4 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Double Tree Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Lyle Furr, Contract Review 

Specialist, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 220, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401. (301) 

435–1439.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.277, Drug Abuse Scientist 

Development Award for Clinicians, Scientist 

Development Awards, and Research Scientist 

Awards; 93.278, Drug Abuse National 

Research Service Awards for Research 

Training; 93.279, Drug Abuse Research 

Programs, National Institutes of Health, 

HHS.)

Dated: January 29, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–2386 Filed 2–4–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel Integrated Preclinical/

Clinical AIDS Vaccine Development 

(IPCAVD). 

Date: February 23–24, 2004. 

Time: 9 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaithersburg Marriott Washington 

Center, 9751 Washington Boulevard, 

Gaithersburg, MD 20878. 

Contact Person: Eleazar Cohen, Phd, 

Scientific Review Administrator, Scientific 

Review Program, National Institute of Allergy 

and Infectious Diseases, DEA/NIH/DHHS, 

6700 B Rockledge Drive, MSC 7616, Room 

3112, Bethesda, MD 20892–7616, 301–435–

3564, ec17w@nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856; 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS)

Dated: January 28, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–2387 Filed 2–4–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Library of 

Medicine Special Emphasis Panel, R21 

Review. 

Date: March 17, 2004. 

Time: 1 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Library of Medicine, 6705 

Rockledge Drive, Suite 301, Bethesda, MD 

20892, (Telephone Conference Call). 

Contact Person: Hua-Chuan Sim, MD, 

Health Science Administrator, National 

Library of Medicine, Extramural Programs, 

Bethesda, MD 20892.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.879, Medical Library 

Assistance, National Institutes of Health, 

HHS)

Dated: January 28, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–2380 Filed 2–4–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Library of 

Medicine Special Emphasis Panel; R03 

Review. 

Date: March 3, 2004. 

Time: 1 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Library of Medicine, 6705 

Rockledge Drive, Suite 301, Bethesda, MD 

20892, (Telephone Conference Call). 

Contact Person: Hua-Chuan Sim, MD, 

Health Science Administrator, National 

Library of Medicine, Extramural Programs, 

Bethesda, MD 20892.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.879, Medical Library 

Assistance, National Institutes of Health, 

HHS.)

Dated: January 28, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–2381 Filed 2–4–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[USCG–2003–16711] 

Cooperative Research and 

Development Agreements

AGENCY: Coast Guard, DHS.